Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sevelamer Carbonate Tablets

Approval Number

国药准字HJ20181037

CompanyGENZYME EUROPE B.V.

Registration Date

August 5, 2022

Previous Approval Numbers

H20181037

Drug Information

Generic Name

碳酸司维拉姆片

Trade Name

诺维乐

Dosage Form

片剂

Strength

800mg

Drug Type

化学药品

Registration Date

August 5, 2022

Expiry Date

August 4, 2027

Company Information

Applicant Company

Company NameGENZYME EUROPE B.V.

Company Address

Paasheuvelweg 25, 1105 BP Amsterdam, The Netherlands

Manufacturing Company

Company NameGENZYME IRELAND LIMITED

Company Address

IDA Industrial Park, Old Kilmeaden Road, Waterford, Ireland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy